Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients [NA]
This completed clinical trial evaluated the effect of increased ambient oxygen during endurance training on patients with stable angina pect…
-
CLINICAL_TRIALS research · 2016-07-19Clinical Trial Update: Validation of Simple Acute Coronary Syndrome (SACS) Score
This clinical trial update reports on the validation of the Simple Acute Coronary Syndrome (SACS) Score for assessing patients with chest pa…
-
FDA approval · 2016-07-15FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for metoprolol succinate from BluePoint Laboratories, enabling continued marketing of this generic b…
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) [Phase 3]
Phase 3 trial evaluating ranolazine for incomplete vessel revascularization after PCI in people with coronary artery disease and angina; the…
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Evaluation of the Correlation Between the Coronary Stenosis Degree With FFRCT and the Grade of Stable Angina Pectoris
An update on a clinical trial investigating the relationship between the degree of coronary stenosis measured by FFRCT and the grade of stab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-06-13FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for metoprolol succinate (generic) from Mylan Pharmaceuticals Inc., resulting in labeling changes as…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Bypass Angioplasty Revascularization Investigation (BARI) [Phase 3]
Completion update of the Phase 3 BARI trial comparing bypass surgery versus angioplasty in patients with coronary disease, highlighting the …
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease [NA]
Dan-NICAD is a Danish study evaluating non-invasive diagnostic testing in coronary artery disease; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships
This NHLBI-supported clinical trial update analyzes the incidence and mortality of coronary heart disease and how various risk factors relat…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients
A completed clinical trial update detailing the pharmacokinetics of low molecular weight heparin in cancer patients.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: The Effect of Exercise on Peripheral Blood Gene Expression in Angina [NA]
A completed clinical trial investigating the effect of exercise on peripheral blood gene expression in patients with angina (angina pectoris…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Cardioprotective Effects of GLP-1 and Their Mechanisms [Phase 1]
Phase 1 trial evaluating whether glucagon-like peptide-1 (GLP-1) has cardioprotective effects and exploring its mechanisms in patients with …
-
FDA label_change · 2016-04-08FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
FDA approved a supplemental application for verapamil hydrochloride, resulting in changes to its labeling.
-
FDA approval · 2016-03-21FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lopressor (metoprolol tartrate) filed by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Thrombolysis in Myocardial Ischemia Trial (TIMI III) [Phase 3]
The Phase 3 TIMI III trial evaluating thrombolysis in myocardial ischemia has completed, with an update posted on the trial registry.
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: Heart Rate Variability (HRV) Testing Compared With Exercise Stress Test in Hospitalized Patients With Chest Pain
This clinical trial update compares heart rate variability testing with an exercise stress test for diagnosing chest pain in hospitalized pa…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Evans County Studies
NHLBI-sponsored clinical trial in Evans County has completed; the study investigated cardiovascular conditions including myocardial infarcti…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Treatment of Reperfusion Event by Vitamin C Infusion [Phase 4]
Phase 4 trial investigating vitamin C infusion for reperfusion events in angina pectoris; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
The clinical trial update summarizes the incidence of diabetes and cardiovascular disease in Mexican Americans and notes the study status as…
-
CLINICAL_TRIALS research · 2016-03-01Clinical Trial Update: Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection [Phase 4]
This update describes a Phase 4 clinical study evaluating the combination of aspirin and Salvianolate Injection for angina in coronary heart…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Epidemiological Tool To Detect Angina Pectoris in Blacks
A completed NHLBI-sponsored trial evaluating an epidemiological tool to detect angina pectoris in Black individuals.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Acute Cardiac Ischemia in Women in the ACI/TIPI Trial
The ACI/TIPI trial update reports that the study focusing on acute cardiac ischemia in women has completed.
-
FDA approval · 2016-01-28FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for amlodipine besylate from Cipla USA Inc.
-
FDA approval · 2016-01-26FDA Approved: NIFEDIPINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for nifedipine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. This action repres…
-
CLINICAL_TRIALS research · 2016-01-22Clinical Trial Update: Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy [Phase 4]
Phase 4 clinical trial update examining bedside CYP2C19 genetic testing to guide antiplatelet therapy in patients undergoing percutaneous co…